Amanda Sheldon, Author at Family Heart Foundation

Familial Hypercholesterolaemia patient-determined themes for community-engaged research

February 23, 2018 /

the Family Heart Foundation is proud to share published research from a Patient Centered Outcomes Research Institute (PCORI)-funded project implemented by the University of Rochester, with the Family Heart Foundation.

The new research published in Health Education Journal aimed to determine individual … Read More →

FDA Approves Evolocumab to Prevent Heart Attack and Stroke

December 4, 2017 /

By Amanda Sheldon /

No Comments

On December 1, the FDA approved evolocumab (Repatha, Amgen) for the prevention of heart attack, stroke, and coronary revascularization in adults with established cardiovascular disease (CVD), as well as for the treatment of adults with primary hyperlipidemia to decrease LDL-C. This is in addition to … Read More →